Newsletter Archive
-
06.18.21 -- A Roadmap For Early Development To Commercial Manufacturing
6/18/2021
06/18/21 BioProcess Online Newsletter
-
06.17.21 -- Key Strategies For Intensifying Your Upstream Bioprocesses
6/17/2021
06/17/21 BioProcess Online Newsletter
-
06.16.21 -- For Applications Requiring Robust Chemical Compatibility -- A Solution Is Here
6/16/2021
06/16/21 BioProcess Online Newsletter
-
06.16.21 -- A Maverick Gene Therapy Manufacturing Strategy
6/16/2021
06/16/21 BioProcess Online Newsletter
-
06.15.21 -- Innovation Begins With A Problem
6/15/2021
06/15/21 BioProcess Online Newsletter
-
06.14.21 -- AAV And Nanogold Characterization Applications
6/14/2021
06/14/21 BioProcess Online Newsletter
-
06.14.21 -- GMP CAR T Manufacturing: The Poseida Approach
6/14/2021
06/14/21 BioProcess Online Newsletter
-
06.12.21 -- Implementing Small-Scale Models For Biopharma Development
6/12/2021
06/12/21 BioProcess Online Newsletter
-
06.12.21 -- Clinical-To-Commercial Perspective On Autologous Cell Therapies
6/12/2021
06/12/21 BioProcess Online Newsletter
-
06.11.21 -- Exosomes' Therapeutic Potential, AAV and Lentiviral Gene Therapies, and more from the Business of Biotech Podcast
6/11/2021
06/11/21 BioProcess Online Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more